Regional chemotherapy for recurrent squamous head and neck cancers through a saphenous vein interposition graft.

Regional chemotherapy for head and neck cancers is effective, but the intra-arterial catheter is not without problems. We interposed a segment of saphenous vein within the carotid system to administer chemotherapeutic agents percutaneously via the arterialized venous segment. From 1983 to 1990, saphenous vein interposition graft was performed after radiotherapy in 24 patients with persistent or recurrent squamous head and neck cancers, which were also considered unresectable. There was no operative mortality. Two patients developed thrombosed vein graft; another two had wound infection; and one patient had a neck hematoma. Cisplatin was administered percutaneously every week via the saphenous vein graft. The response rate was 64% (complete response, 23%; partial response, 41%), and the 5-year actuarial survival rate was 31%. The 1-year survival rates for patients with complete, partial, and no response were 80%, 33%, and 13%, respectively. Saphenous vein interposition graft is a safe and convenient way of delivering intra-arterial chemotherapy, and it provides significant palliation for patients with recurrent nonresectable squamous head and neck cancers after radiotherapy.

[1]  S. Monfardini,et al.  Induction intra‐arterial cisplatin and bleomycin in head and neck cancer , 1991, Head & neck.

[2]  S. Ellenberg,et al.  A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  G. Laramore,et al.  Feasibility and efficacy of weekly intraarterial cisplatin in locally advanced (stage III and IV) head and neck cancers. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Savin,et al.  A pilot study of intraarterial chemotherapy with cisplatin in locally advanced head and neck cancers , 1988, Cancer.

[5]  S. Baker,et al.  Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  W. Wei,et al.  Regional chemotherapy through a saphenous vein graft for the treatment of head and neck cancers , 1987, Cancer.

[7]  P. Engstrom,et al.  Sequential methotrexate and 5‐fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck , 1986, Cancer.

[8]  S. Raina,et al.  Preoperative intra‐arterial infusion chemotherapy for advanced squamous cell carcinoma of the mouth and oropharynx , 1985, Cancer.

[9]  W. Hong,et al.  Chemotherapy in head and neck cancer. , 1983, The New England journal of medicine.

[10]  S. Baker,et al.  Single‐agent and combination‐drug regional chemotherapy for head and neck cancer using an implantable infusion pump , 1984 .

[11]  H. Lerner,et al.  Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck. , 1984, Cancer treatment reports.

[12]  E. Kastenbauer,et al.  A special method of intra-arterial infusion for treatment of head and neck cancer. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[13]  W. Mattsson,et al.  INTRA-ARTERIAL CHEMOTHERAPY , 1980, The Lancet.

[14]  W. Donegan,et al.  Regional chemotherapy with combined drugs in cancer of the head and neck , 1976, Cancer.

[15]  Blake Cady,et al.  Regional arterial chemotherapy for advanced carcinoma of the head and neck. A ten‐year review , 1973, Cancer.